Johns Hopkins Psychiatry Guide
Asenapine
INDICATIONS
FDA
FDA
- Schizophrenia
- Bipolar I disorder as maintenance monotherapy or adjunctive therapy to lithium or valproate
- Acute monotherapy for treatment of mania or mixed episodes (adults and pediatrics)
- Note: Transdermal patch only has schizophrenia indication.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 29, 2025
Citation
Qureshi, Imran. "Asenapine." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787497/0.0/Asenapine.
Qureshi I. Asenapine. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787497/0.0/Asenapine. Accessed October 31, 2025.
Qureshi, I. (2025). Asenapine. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787497/0.0/Asenapine
Qureshi I. Asenapine [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787497/0.0/Asenapine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Asenapine
ID - 787497
A1 - Qureshi,Imran,PharmD, BCPP
Y1 - 2025/08/29/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787497/0.0/Asenapine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
